tiprankstipranks
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Germany Market

KalVista Pharmaceuticals (4XC1) Cash flow

Compare
0 Followers

KalVista Pharmaceuticals Cash Flow

DE:4XC1's free cash flow for Q2 2025 was $-39.84M. For the 2025 fiscal year, DE:4XC1's free cash flow was decreased by $-13.22M and operating cash flow was $-39.64M. See a summary of the company’s cash flow.
Cash Flow
Jun 24Jun 23Jun 22Jun 21Jun 20
Operating Cash Flow
$ -89.23M$ -75.26M$ -78.13M$ -30.17M$ -44.82M
Investing Cash Flow
$ -84.72M$ 41.41M$ 57.86M$ -147.65M$ 16.75M
Financing Cash Flow
$ 150.71M$ 58.12M$ 1.58M$ 212.12M$ 11.58M
End Cash Position
$ 31.79M$ 56.24M$ 30.73M$ 50.59M$ 15.79M
Free Cash Flow
$ -89.67M$ -76.46M$ -79.06M$ -30.25M$ -45.04M
Currency in USD

KalVista Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis